PPARγ Activation Increases ROS Production and Cell Cycle Progression in Lung Cells
Author Information
Author(s): Tickner Jennifer, Fan Lampson M., Du Junjie, Meijles Daniel, Li Jian-Mei
Primary Institution: Faculty of Health and Medical Sciences, University of Surrey
Hypothesis
PPARγ activation influences ROS production and cell-cycle progression in lung alveolar epithelial cells.
Conclusion
PPARγ activation through Nox2-derived ROS promotes cell-cycle progression in normal mouse lungs and in cultured normal alveolar epithelial cells.
Supporting Evidence
- GW1929 treatment increased ROS production in wild-type lungs but not in Nox2 knockout mice.
- PPARγ activation led to increased expression of cell-cycle proteins PCNA and cyclin D1.
- Cell-cycle progression was promoted from G0/G1 into S and G2/M phases in cultured alveolar epithelial cells.
Takeaway
When a specific drug activates a protein called PPARγ, it makes lung cells produce more reactive oxygen species (ROS), which helps them grow and divide.
Methodology
The study used both in vivo and in vitro experiments with wild-type and Nox2 knockout mice, measuring ROS production and cell-cycle progression after PPARγ activation.
Potential Biases
Potential bias in interpreting the effects of PPARγ activation due to the use of specific agonists and knockout models.
Limitations
The study primarily focused on mouse models, which may not fully represent human lung biology.
Participant Demographics
Middle-aged male mice (6–7 months old).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website